News for 'Sun Pharma'

Sensex drops 245 points on persistent foreign fund outflows

Sensex drops 245 points on persistent foreign fund outflows

Rediff.com14 Jan 2026

From the 30-Sensex firms, Tata Consultancy Services, Asian Paints, Maruti, Sun Pharma, Hindustan Unilever, ICICI Bank, Kotak Mahindra Bank, Tech Mahindra, HDFC Bank and Larsen & Toubro were among the biggest laggards. On the other hand, Tata Steel, NTPC, Axis Bank and UltraTech Cement were among the gainers.

Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%

Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%

Rediff.com23 May 2025

India's largest drug maker Sun Pharmaceutical on Thursday posted a decline of 19 per cent year-on-year (Y-o-Y) for its consolidated net profit for the fourth quarter of the financial year 2025 (Q4FY25) at Rs 2,149.8 crore. Meanwhile, its revenue from operations rose by 8 per cent at Rs 12,958.8 crore.

Sensex slips 43 pts; IT shares fall on profit-taking

Sensex slips 43 pts; IT shares fall on profit-taking

Rediff.com23 Dec 2025

Among Sensex firms, Infosys, Bharti Airtel, Adani Ports, Sun Pharma, Tech Mahindra, Eternal, Axis Bank and Maruti were the major laggards. However, ITC, UltraTech Cement, Tata Steel and HDFC Bank were among the gainers.

Budget 2026 boosts healthcare spend, drugs relief

Budget 2026 boosts healthcare spend, drugs relief

Rediff.com1 Feb 2026

The government on Sunday gave a strong push to upgradation and expansion of healthcare infrastructure, medical education and pharma sector with the Union Budget 2026-27 announcing a slew of steps, including those aimed at making India a global hub for allied healthcare professionals and biopharma manufacturing.

Indian Pharma Gets Relief from Trump's Tariffs

Indian Pharma Gets Relief from Trump's Tariffs

Rediff.com4 Apr 2025

Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages.

This will Likely Shape the Future of Pharma Inc

This will Likely Shape the Future of Pharma Inc

Rediff.com8 Mar 2025

Indian pharmaceutical companies may have units abroad as part of "distributed manufacturing" across various locations, according to industry veterans. This may come about over the next five to 10 years.

15 killed, 34 hurt in explosion at Telangana pharma plant

15 killed, 34 hurt in explosion at Telangana pharma plant

Rediff.com1 Jul 2025

At least 12 people died and 34 persons were injured in a pharma plant explosion in Sangareddy district of Telangana on Monday, State Minister Damodara Raja Narasimha said.

Sensex jumps 487 points on optimism over India-EU FTA

Sensex jumps 487 points on optimism over India-EU FTA

Rediff.com28 Jan 2026

From the 30-Sensex firms, Bharat Electronics surged nearly 9 per cent post its December quarter earnings. Eternal, Bajaj Finance, Power Grid, Trent, Mahindra & Mahindra and UltraTech Cement were the other major gainers. Maruti, Sun Pharma, Infosys and Bharti Airtel were among the other laggards.

What India gives, and what it gets: Highlights of India-US interim trade deal

What India gives, and what it gets: Highlights of India-US interim trade deal

Rediff.com7 Feb 2026

Both countries commit to provide each other preferential market access in sectors of respective interest on a sustained basis

Budget 2026 is cautious and also focussed on the long-term journey

Budget 2026 is cautious and also focussed on the long-term journey

Rediff.com10 Feb 2026

This year's Economic Survey and the Union Budget were more closely followed for more reasons than one.

Sensex tanks over 1,000 points, Nifty tumble over 1%

Sensex tanks over 1,000 points, Nifty tumble over 1%

Rediff.com20 Jan 2026

From the 30-Sensex firms, Eternal declined by 4.02 per cent, followed by Bajaj Finance (3.88 per cent), Sun Pharma, InterGlobe Aviation, Trent, Asian Paints, Mahindra & Mahindra and Bajaj Finserv. HDFC Bank emerged as the only gainer from the pack.

Market Guru: 'This Is About Capital Preservation'

Market Guru: 'This Is About Capital Preservation'

Rediff.com18 Feb 2026

'The problem is not just slower growth, but also the quality of growth.'

India, US to sign interim trade deal in March: Goyal

India, US to sign interim trade deal in March: Goyal

Rediff.com20 Feb 2026

Commerce and Industry Minister Piyush Goyal announced that an interim trade agreement between India and the US is likely to be signed in March and operationalised in April, with chief negotiators meeting in Washington to finalize the details.

Stock markets end higher on rally in Infosys shares

Stock markets end higher on rally in Infosys shares

Rediff.com16 Jan 2026

Tech Mahindra, HCL Tech, State Bank of India, UltraTech Cement and HDFC Bank were also among the gainers. In contrast, Eternal, Asian Paints, Bharat Electronics, Sun Pharma and Maruti were among the laggards.

Sensex sheds 367 points on foreign fund outflows

Sensex sheds 367 points on foreign fund outflows

Rediff.com26 Dec 2025

From the 30-Sensex firms, Bajaj Finance, Asian Paints, HCL Tech, Tata Consultancy Services, Eternal and Sun Pharma were among the biggest laggards. However, Titan, NTPC, Axis Bank, UltraTech Cement, Reliance Industries and Hindustan Unilever were the gainers.

Investors lost Rs 9.40 lakh cr in Budget Sunday crash

Investors lost Rs 9.40 lakh cr in Budget Sunday crash

Rediff.com1 Feb 2026

The market capitalisation of BSE-listed companies eroded by Rs 9,40,581.75 crore to Rs 4,50,61,658.60 crore (USD 4.90 trillion) in a single day.

Sigachi Industries CEO held over Telangana plant blast

Sigachi Industries CEO held over Telangana plant blast

Rediff.com28 Dec 2025

A top executive of Sigachi Industries has been arrested in connection with the explosion at its pharma plant in Telangana in June, which resulted in 54 deaths.

Sensex, Nifty tank nearly 1%

Sensex, Nifty tank nearly 1%

Rediff.com9 Jan 2026

From the 30-Sensex firms, NTPC, ICICI Bank, Adani Ports, Bharti Airtel, Sun Pharma and Bajaj Finance were among the biggest laggards. However, Asian Paints, HCL Tech, Bharat Electronics and Reliance Industries were among the gainers.

Stock markets surge nearly 1% on last trading session of 2025

Stock markets surge nearly 1% on last trading session of 2025

Rediff.com31 Dec 2025

From the 30-Sensex firms, Tata Steel, Kotak Mahindra Bank, Reliance Industries, Axis Bank, Titan and Trent were among the biggest gainers. However, Tata Consultancy Services, Tech Mahindra, Infosys, Bajaj Finance and Sun Pharma, were the laggards.

Centre mandates blue strip on antimicrobial drugs to curb overuse

Centre mandates blue strip on antimicrobial drugs to curb overuse

Rediff.com24 Jan 2026

The Union health ministry has issued draft rules to mandate a blue vertical strip on all antimicrobial drug labels, aiming to rein in over-the-counter misuse and tackle India's growing antimicrobial resistance (AMR) problem.

Pharma companies fight fakes with smart packaging

Pharma companies fight fakes with smart packaging

Rediff.com10 Oct 2024

Indian pharmaceutical companies are stepping up their efforts to combat the problem of counterfeit drugs, employing a variety of strategies, from packaging innovations to engaging private investigation agencies. The stakes are high, as counterfeit medicines not only harm consumers but also tarnish the reputation of leading brands.

'Good night, Happy New Year': Maduro's 1st words after US capture

'Good night, Happy New Year': Maduro's 1st words after US capture

Rediff.com4 Jan 2026

The Venezuelan President and his wife Cilia Flores were earlier captured from Caracas after US President Donald Trump unilaterally sanctioned a military operation on Venezuelan soil.

Now, Isn't Shruti Sweet?

Now, Isn't Shruti Sweet?

Rediff.com22 Dec 2025

Shruti Ramachandran's style lives in that sweet spot where simplicity meets a quiet edge.

Maduro, wife to appear in New York court today

Maduro, wife to appear in New York court today

Rediff.com5 Jan 2026

Venezuelan President Nicolas Maduro and his wife, Cilia Flores, are set to appear before a federal judge on Monday, after United States authorities confirmed that the case will be heard in the Southern District of New York on Sunday, CBS News reported.

Sensex down 376 points on selling in RIL, HDFC Bank

Sensex down 376 points on selling in RIL, HDFC Bank

Rediff.com6 Jan 2026

Reliance Industries cracked 4.42 per cent, while ITC, Kotak Mahindra Bank, InterGlobe Aviation, and HDFC Bank were also among the laggards. However, ICICI Bank, Sun Pharma, Hindustan Unilever, and State Bank of India were among the gainers.

'14+ Anti-Obesity Drugs In The Pipeline'

'14+ Anti-Obesity Drugs In The Pipeline'

Rediff.com13 Dec 2025

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.

Sensex down 78 points on weak global trends

Sensex down 78 points on weak global trends

Rediff.com18 Dec 2025

Among Sensex firms, Sun Pharma, Tata Steel, Power Grid, Asian Paints, NTPC and Bharti Airtel were the biggest laggards. Tata Consultancy Services, Tech Mahindra, Infosys, Adani Ports, Axis Bank and HCL Tech were among the gainers.

Dr Reddy's profit down 14% on low Lenalidomide US sales

Dr Reddy's profit down 14% on low Lenalidomide US sales

Rediff.com22 Jan 2026

Pharma major Dr Reddy's Laboratories (DRL) reported a 14 per cent year-on-year (Y-o-Y) drop in consolidated net profit to Rs 1,210 crore in the December quarter of FY 2025-26 (Q3FY26) on low sales of cancer drug Lenalidomide in the North American market. The firm's revenue from operations grew to Rs 8,727 crore in Q3FY26, a 4.4 per cent Y-o-Y increase from Rs 8,357 crore recorded for the same quarter last year.

Smallcap To Watch Out For In 2026

Smallcap To Watch Out For In 2026

Rediff.com4 Feb 2026

After two years of strong gains, smallcap stocks fell sharply in 2025, but the correction may be setting up opportunities for long-term investors.

Sensex jumps 448 points on fresh fund inflows

Sensex jumps 448 points on fresh fund inflows

Rediff.com19 Dec 2025

From the 30-Sensex firms, Bharat Electronics, Power Grid, Tata Motors Passenger Vehicles, Asian Paints, Reliance Industries, and Bajaj Finserv were among the biggest gainers. However, HCL Tech, Kotak Mahindra Bank, ICICI Bank, and Sun Pharma were the laggards.

Ambitious, futuristic: PM Modi lauds Sitharaman's 9th Budget

Ambitious, futuristic: PM Modi lauds Sitharaman's 9th Budget

Rediff.com1 Feb 2026

Reiterating Sitharaman's statement that this is a youth power budget, Modi emphasised that the provisions made in the budget will prepare leaders, innovators and creators across different sectors.

Budget 2026: Time To Fix The Weak Link In R&D Ecosystem

Budget 2026: Time To Fix The Weak Link In R&D Ecosystem

Rediff.com31 Jan 2026

Restoring weighted tax deductions and adopting a petty patents regime can foster firm-level innovative activity critical for competitiveness, points out Nagesh Kumar.

Ozempic launched in India, priced at Rs 2,200 per week

Ozempic launched in India, priced at Rs 2,200 per week

Rediff.com12 Dec 2025

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits.

Mankind taps OpenAI to institutionalise AI in ops

Mankind taps OpenAI to institutionalise AI in ops

Rediff.com18 Sep 2025

Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI) across its value chain, making it one of the first few Indian pharmaceutical companies to fully integrate advanced AI into its core operations.

Startups go vertical in India's qcom race

Startups go vertical in India's qcom race

Rediff.com24 Oct 2025

As the quick commerce (qcom) race hots up, a new model - vertical qcom - is gaining investor attention. Unlike horizontal players such as Blinkit, Zepto, and Swiggy Instamart, which stock everything from groceries to gifts and gadgets, vertical platforms focus on depth over breadth.

The side effects are real, but Sun Pharma stays on its feet

The side effects are real, but Sun Pharma stays on its feet

Rediff.com21 Apr 2025

After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries, has clawed back nearly half of those losses. Recent acquisitions, a favourable court ruling in the case of the hair loss drug Leqselvi, an edge over peers owing to its specialty portfolio, and a diversified global presence have supported the recovery.

Weightloss Drugs Hit 1,000 Crore Mark

Weightloss Drugs Hit 1,000 Crore Mark

Rediff.com22 Dec 2025

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'

Stock markets end lower in volatile trade

Stock markets end lower in volatile trade

Rediff.com24 Dec 2025

From the 30-Sensex firms, InterGlobe Aviation, Sun Pharma, Asian Paints, Reliance Industries, Hindustan Unilever, and Tata Steel were among the biggest laggards. However, Trent, UltraTech Cement, Maruti, and Power Grid were among the gainers.

'Money Comes Only When Markets Do Well'

'Money Comes Only When Markets Do Well'

Rediff.com4 Feb 2026

'Given that India underperformed emerging markets by 28 per cent in 2025, the worst performance in over 30 years, the timing of the sharp STT hike could have been better.'

India, EU free trade deal to likely conclude on Jan 27

India, EU free trade deal to likely conclude on Jan 27

Rediff.com25 Jan 2026

India and the European Union are set to announce on January 27 the conclusion of negotiations and finalisation of a free trade agreement, which is aimed at boosting economic ties between the two regions amid disruptions in global trade due to US tariffs, an official said.